Sarah K. Schröder-Lange is a postdoctoral researcher at the Institute of Molecular Pathobiochemistry, Experimental Gene Therapy and Clinical Chemistry (IFMPEGKC) at RWTH Aachen University. Over the past seven years, her research has concentrated on the protein lipocalin 2 (LCN2) in health and disease. She completed her PhD in 2021, researching the role and function of LCN2 in prostate cancer. Since then, she has been consistently working on various projects to further understand the physiological and pathophysiological roles, as well as the signalling mechanisms of this protein in reproductive health (and disease). She has expertise in various biological disciplines and techniques, such as molecular biology, biochemistry and cell culture studies.